Menu

Image of the Day: Pleistocene Footprints

Researchers find impressions left by a human some 13,000 years ago in British Columbia.

Mar 29, 2018
The Scientist Staff, The Scientist Staff

Photo of a footprint (left) and a digitally-enhanced image of the footprint (right) from a human who lived 13,000 years agoDUNCAN MCLAREN

Archaeologists searching a beach on Canada’s Pacific Coast found something amazing: a footprint left there by a human 13,000 years ago. Researchers reported yesterday (March 28) in PLOS ONE that they uncovered this and 29 other footprints on an island in the Hakai Protected Area, an archipelago off the coast of British Columbia.

Sea levels were lower 13,000 years ago than they are now because much of the Earth’s water was locked up in glaciers; in the search area, the difference was as much as 2-3 meters. The researchers were looking for archaeological deposits in that intertidal area when they were surprised to find the footprints. They used radiocarbon dating to estimate their age and analyzed them digitally to determine they most likely belonged to two adults and a child.  

D. McLaren et al., “Terminal Pleistocene epoch human footprints from the Pacific coast of Canada,” PLOS ONE, doi:10.1371/journal.pone.0193522, 2018.

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!